The data from our studies provide a mechanistic explanation for these previous findings and further support that enhancing tumor-reactive T cell–derived TNF (perhaps one consequence of overcoming T cell exhaustion) and sensitizing tumor cells to programmed cell death may be useful strategies in tumor immunotherapy. Here, TNF is linked to neoplasm.